| Biological Process | Role of Serrapeptase Target | Pregnancy Risk | |-------------------|-----------------------------|----------------| | Implantation (days 6–12) | Degrades fibronectin & laminin in decidua | Failed implantation / early loss | | Placentation (weeks 8–12) | Disrupts trophoblast ECM remodeling | Preeclampsia, IUGR | | Fibrinogen maintenance | Cleaves fibrin (fibrinolytic) | Placental abruption, hemorrhage | | Cervical mucus plug | Proteolysis of mucus glycoproteins | Ascending infection, PPROM | | Fetal membrane strength | Collagen IV degradation | Preterm premature rupture of membranes (PPROM) |
Based on the precautionary principle and the absence of safety data:
Serrapeptase is a proteolytic enzyme originally isolated from silkworms. While it is often marketed as a "miracle enzyme" for reducing inflammation and breaking down non-living tissue, its use in a prenatal context presents several significant concerns:
Serrapeptase is a proteolytic enzyme that is produced by the bacterium Serratia peptidase . It works by breaking down protein-based tissues, including scar tissue, and has anti-inflammatory properties. Serrapeptase has been used in Europe for many years to treat a range of conditions, including inflammation, edema, and even some types of cancer. serrapeptase pregnancy
As a dietary supplement, serrapeptase is not subjected to the same rigorous federal safety standards as prescription medications. Serrapeptase and Fertility
Serrapeptase is a proteolytic enzyme derived from the silkworm ( Bombyx mori ), marketed for its anti-inflammatory and fibrinolytic properties. Despite its over-the-counter availability, safety data during human pregnancy are absent. This paper reviews the pharmacological rationale for potential fetotoxicity and teratogenicity.
Data on the long-term safety of this enzyme is lacking, and its precise molecular mechanism in the human body is not fully understood. | Biological Process | Role of Serrapeptase Target
Some medical resources even suggest using reliable birth control while taking serrapeptase if you plan to become pregnant soon. Serrapeptase and Fertility
Health Canada specifically lists "do not use if you are pregnant or breastfeeding" on product information for serrapeptase supplements.
Despite marketing as a “natural” supplement, regulatory bodies (FDA, EMA) have not evaluated serrapeptase for pregnancy safety. This paper synthesizes mechanistic, animal, and theoretical risks. Serrapeptase has been used in Europe for many
The American College of Obstetricians and Gynecologists (ACOG) and other reputable medical organizations do not recommend the use of serrapeptase during pregnancy, as there is limited research on its safety and efficacy in pregnant women.
Some potential risks and concerns associated with serrapeptase use during pregnancy include: